Jingshuo Chen Selected Research

Acyl Coenzyme A (Acyl CoA)

1/2023

Inhibition of mPGES-2 ameliorates NASH by activating NR1D1 via heme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingshuo Chen Research Topics

Disease

2	Fibrosis (Cirrhosis) 04/2024 - 01/2023
1	Type 2 Diabetes Mellitus (MODY) 04/2024
1	Acute Kidney Injury (Acute Renal Failure) 10/2023
1	Ischemia 10/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Inflammation (Inflammations) 01/2023

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 04/2024 - 01/2023
1	Insulin (Novolin)FDA Link 04/2024
1	ProstaglandinsIBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 10/2023
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2023
1	Choline (Choline Chloride)IBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	Methionine (L-Methionine)FDA Link 01/2023
1	Prostaglandins EIBA 01/2023
1	Member 1 Group D Nuclear Receptor Subfamily 1IBA 01/2023
1	heme receptorIBA 01/2023

Therapy/Procedure

2	Therapeutics 10/2023 - 01/2023